DIAGNOS Inc.
DIAGNOS Inc. (ADK.V) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
adk.v · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for DIAGNOS Inc. (ADK.V) measures how much investors pay for each dollar of the company's trailing earnings. ADK.V's current PE ratio of N/A is calculated by dividing its stock price of $0.21 by its TTM earnings per share of -$0.04.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
DIAGNOS Inc.You ADK.V | $22M | N/A | — | -$0.04 |
 Avicanna Inc. AVCN.TO | $14M | N/A | — | -$0.02 |
 BioMark Diagnostics Inc. BUX.CN | $61M | N/A | — | -$0.02 |
 Charlotte's Web Holdings, Inc. CWEB.TO | $96M | N/A | — | -$0.19 |
 Gemina Laboratories Ltd. GLAB.CN | $5M | N/A | — | -$0.06 |
 Izotropic Corporation IZO.CN | $19M | N/A | — | -$0.05 |
 MediPharm Labs Corp. LABS.TO | $30M | N/A | — | -$0.02 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | — | $-0.05 | — | |
2024-03-31 FY2024 | — | $-0.04 | — | |
2023-03-31 FY2023 | — | $-0.04 | — | |
2022-03-31 FY2022 | — | $-0.03 | — | |
2021-03-31 FY2021 | — | $-0.05 | — | |
2020-03-31 FY2020 | — | $-0.09 | — | |
2019-03-31 FY2019 | — | $-0.20 | — | |
2018-03-31 FY2018 | — | $-0.17 | — | |
2017-03-31 FY2017 | — | $-0.44 | — | |
2016-03-31 FY2016 | — | $-0.30 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for DIAGNOS Inc. (ADK.V) measures how much investors pay for each dollar of the company's trailing earnings. ADK.V's current PE ratio of N/A is calculated by dividing its stock price of $0.21 by its TTM earnings per share of -$0.04.
Frequently asked questions
ADK.V pe ratio · 6 questionsADK.V's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.21 and TTM EPS of -$0.04. Data sourced from Financial Modeling Prep via ADK.V's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · DIAGNOS Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08